DexCom, Inc. (LON:0A4M)
78.28
0.00 (0.00%)
At close: Sep 10, 2025
DexCom Market Cap
DexCom has a market cap or net worth of 21.79 billion as of September 16, 2025. Its market cap has increased by 1.87% in one year.
Market Cap
21.79B
Enterprise Value
21.54B
Revenue
3.14B
Ranking
n/a
PE Ratio
52.25
Stock Price
78.28
Market Cap Chart
Since April 14, 2005, DexCom's market cap has increased from 157.23M to 21.79B, an increase of 13,761.09%. That is a compound annual growth rate of 27.29%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 15, 2025 | 21.79B | -10.18% |
Dec 31, 2024 | 24.26B | -35.54% |
Dec 29, 2023 | 37.64B | 3.69% |
Dec 30, 2022 | 36.30B | -5.55% |
Dec 31, 2021 | 38.43B | 47.80% |
Dec 31, 2020 | 26.00B | 72.02% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 182.89B |
HSBC Holdings | 173.69B |
Shell | 153.74B |
Unilever | 115.27B |
Rolls-Royce Holdings | 94.89B |
British American Tobacco p.l.c. | 90.77B |
Rio Tinto Group | 78.69B |
BP p.l.c. | 64.96B |